K. Nadesalingam

Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by patients with cystic fibrosis.

M. Denton, S. Conway, K. Nadesalingam, 2005, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Halo naevi, vitiligo and diffuse alopecia areata associated with tocilizumab therapy

P. Emery, M. Goodfield, K. Nadesalingam, 2016, Oxford medical case reports.